![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
ECHA InfoCard | 100.051.185 ![]() |
Chemical and physical data | |
Formula | C22H27ClN2O3 |
Molar mass | 402.92 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Lorajmine (17-monochloroacetylajmaline) is a drug that is a potent sodium channel blocker (more specifically, a class Ia antiarrhythmic agent) that was used for treating arrhythmia.[1][2][3] It is derived from ajmaline, an alkaloid from the roots of Rauvolfia serpentina, by synthetically adding a chloroacetate residue.
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Channel blockers |
| ||||||||||||
Receptor agonists and antagonists |
| ||||||||||||
Ion transporters |
| ||||||||||||
|
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |